Quo-Lab meets strict international quality targets – confirming it fit for purpose for diabetes testing The study aimed to evaluate the four POC HbA1c instruments according to Clinical and Laboratory ...

Diabetes Mellitus has become a worldwide epidemic, affecting approximately 425 million people. Unfortunately, one in two patients remains undiagnosed. HbA1c can play a major role in finding these ...

New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2–6 October) and published in the journal Diabetes Therapy suggests that ...

Diabetes represents a serious global epidemic. Diabetes causes its own direct adverse effects but also predisposes patients to the development of both cardiovascular disease (CVD) and chronic kidney ...

EKF Diagnostics, the global in vitro diagnostics company, announces that a recent study has confirmed that its Quo-Test® A1c point-of-care testing (POCT) analyzer shows comparable performance to a lab ...

While several trials have shown that substantial weight loss using diet and lifestyle can reverse type 2 diabetes, new research published in Diabetologia is among the first to show the subsequent ...